How Much Bacteriostatic Water for Melanotan 1? (Chart)

Determining Bacteriostatic Water Volume for Melanotan 1 Reconstitution

Determining how much bacteriostatic water for Melanotan 1 reconstitution requires balancing target concentration, volumetric measuring precision, and solution stability. Reconstitution is the process of restoring a lyophilized peptide cake into a homogeneous liquid solution suitable for in vitro assays or preclinical animal models. Because Melanotan 1 is typically supplied as a 10 mg lyophilized powder, the volume of bacteriostatic water (0.9% benzyl alcohol in sterile water for injection) added directly dictates the final concentration in milligrams per milliliter (mg/mL) or micrograms per microliter (µg/µL).

Laboratory investigators must select a diluent volume that matches their experimental pipetting capabilities. Adding insufficient diluent (e.g., under 0.5 mL) creates an excessively concentrated stock solution where minor pipetting discrepancies lead to large percentage errors in delivered peptide mass. Conversely, diluting the sample with excessive volume (e.g., greater than 5.0 mL) can introduce osmotic imbalances in cell culture media or result in working concentrations that exceed the volumetric capacity of microplate wells or specialized injection apparati. For automated or manual tools, utilizing our digital reconstitution calculator ensures precise mathematical conversion prior to laboratory work.

Melanotan 1 Reconstitution Chart for 10 mg Lyophilized Vials

The following quantitative lookup table outlines the resulting concentrations when reconstituting a standard 10 mg vial of high-purity Melanotan 1 with varying volumes of bacteriostatic water. Researchers can cross-reference their desired target working dosage per microliter against the required diluent fill.

• 1.0 mL Diluent Addition: Yields a final concentration of 10.0 mg/mL (10.0 µg/µL). Recommended for high-concentration stock preparation, long-term frozen aliquoting, or minimal volume micro-dispensing. • 2.0 mL Diluent Addition: Yields a final concentration of 5.0 mg/mL (5.0 µg/µL). Standard benchmark dilution providing optimal pipetting accuracy across most standard laboratory volumetric ranges. • 2.5 mL Diluent Addition: Yields a final concentration of 4.0 mg/mL (4.0 µg/µL). Ideal for intermediate dosing protocols requiring whole-number concentration increments during dilution series. • 3.0 mL Diluent Addition: Yields a final concentration of 3.33 mg/mL (3.33 µg/µL). Suitable for larger working volumes where minor volumetric pipetting variations must be minimized. • 5.0 mL Diluent Addition: Yields a final concentration of 2.0 mg/mL (2.0 µg/µL). Preferred for extensive dilute assays, organ bath preparations, or high-volume micro-perfusion setups.

Selecting the appropriate volume from this reference ensures that laboratory personnel maintain precise control over peptide molarity without exceeding vial volume capacities or risking solubility saturation.

Mathematical Formulas and Concentration Calculations for In Vitro Protocols

The fundamental equation governing peptide reconstitution is C = m / V, where C represents the final concentration, m represents the mass of the lyophilized peptide in milligrams, and V represents the volume of reconstituted diluent in milliliters. To calculate the concentration resulting from adding 2.0 mL of bacteriostatic water to a 10 mg vial of Melanotan 1, the arithmetic is expressed as: C = 10 mg / 2.0 mL = 5.0 mg/mL.

To convert this stock concentration to microgram-per-microliter units for micro-assay protocols, note that 1.0 mg/mL is mathematically equivalent to 1.0 µg/µL. Thus, a 5.0 mg/mL solution contains exactly 5.0 µg of active Melanotan 1 per microliter of solution. If an in vitro assay requires a working concentration of 50 µg per culture well, the required pipetting volume of stock solution is calculated via V_required = Target Mass / Stock Concentration = 50 µg / (5.0 µg/µL) = 10 µL. Maintaining rigorous mathematical verification prevents systematic errors in experimental bioassays across our full catalog of research peptides.

Physicochemical Profile and Melanocortin Activity of Melanotan 1

Melanotan 1 (also known as Afamelanotide or [Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2]) is a synthetic peptide analog of endogenous alpha-melanocyte-stimulating hormone (α-MSH). Chemically modified with a D-phenylalanine substitution at position 7 and a norleucine substitution at position 4, the molecule exhibits enhanced metabolic stability against enzymatic cleavage compared to native α-MSH.

In preclinical literature, Melanotan 1 functions as a potent, non-selective melanocortin receptor agonist. Grounding studies indicate that it is primarily researched for melanocortin activity related to skin pigmentation responses and melanogenesis signaling pathways. Preclinical rodent models and in vitro cell culture assays demonstrate that Melanotan 1 selectively binds to the melanocortin 1 receptor (MC1R) on melanocytes, stimulating adenylate cyclase activity and intracellular cyclic AMP (cAMP) accumulation. This cascade upregulates tyrosinase transcription, driving the synthesis of eumelanin without requiring direct ultraviolet radiation exposure.

Comparative Analysis: Melanotan 1 vs Related Melanocortin Agonists

When designing comparative melanocortin signaling assays, investigators often compare Melanotan 1 against other synthetic peptides in the same structural and functional class. While Melanotan 1 maintains a linear peptide chain designed specifically to target MC1R for pigmentation bioassays, cyclic analogs like Melanotan 2 possess a shortened, constrained structure that displays broader central nervous system receptor activity, including potent binding at MC3R and MC4R.

Similarly, research compounds like PT-141 (Bremelanotide)—a metabolite derivative of Melanotan II—are investigated primarily for central nervous system melanocortin receptor pathways regulating behavioral responses rather than cutaneous pigmentation. Understanding these structural and receptor affinity differences allows researchers to select the precise analog required for their specific pathway analysis in our wider peptide research library.

Step-by-Step Laboratory Reconstitution Standard Operating Procedure

To maintain sterility and structural integrity during reconstitution, laboratory technicians should follow a standardized cleanroom or laminar flow hood protocol:

1. Preparation: Sanitize the workspace surface with 70% isopropyl alcohol. Allow the lyophilized Melanotan 1 vial and the bacteriostatic water diluent to equilibrate to room temperature (20°C to 25°C) prior to fluid entry to minimize thermal shock. 2. Vial Disinfection: Remove the flip-off protective caps from both vials. Wipe the exposed rubber septa with separate, sterile 70% isopropyl alcohol swabs and allow them to air dry completely for 30 seconds. 3. Diluent Extraction: Using a sterile, single-use syringe fitted with a 21 to 25-gauge needle, draw the exact pre-calculated volume of bacteriostatic water (e.g., 2.0 mL). 4. Controlled Injection: Insert the needle through the center of the Melanotan 1 vial septum at a 45-degree angle. Aim the needle tip against the glass inner wall of the vial. Slowly depress the plunger, allowing the diluent to stream gently down the glass wall onto the lyophilized cake. Avoid splashing or direct high-pressure stream injection onto the dry powder. 5. Dissolution: Gently swirl the vial in a smooth circular motion on the benchtop. Do not shake, vortex, or agitate violently, as shear forces can break peptide bonds and induce protein aggregation. Wait 2–5 minutes for the cake to fully dissolve into a clear, colorless, particle-free solution.

Aliquoting, Storage Stability, and Handling Parameters

Lyophilized Melanotan 1 powder maintains long-term chemical stability when stored desiccated at -20°C to -80°C, protected from light exposure. Once reconstituted with bacteriostatic water, the benzyl alcohol preservative inhibits microbial proliferation, allowing the stock solution to remain stable under refrigeration (2°C to 8°C) for up to 28 days.

For protocols requiring longer evaluation windows, the reconstituted solution should be immediately aliquoted into single-use, sterile polypropylene micro-centrifuge tubes to prevent repeated freeze-thaw cycles. Multiple freeze-thaw events cause ice crystal formation that degrades peptide peptide integrity and alters molar concentration. Aliquots stored at -20°C or -80°C remain stable for 6 to 12 months. Ensure all primary vials and sub-aliquots are labeled with the precise concentration, date of reconstitution, and lot number derived from the primary packaging.

Analytical Quality Assurance: COAs, HPLC, and Endotoxin Testing

Experimental reproducibility requires strict raw material purity and verified chemical composition. PX1 Research subjects every synthesis batch of Melanotan 1 to rigorous analytical validation in an ISO 17025 accredited testing facility. Purity is verified using High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to confirm sequence identity and molecular weight integrity.

We guarantee a minimum chemical purity of ≥99.0% for all research compounds. Furthermore, because bacterial lipopolysaccharides can alter cell culture viability and introduce non-specific immune responses in preclinical models, our compounds undergo Chromogenic LAL Endotoxin Testing to ensure levels fall below strict laboratory thresholds (<0.05 EU/mg). Researchers can review lot-specific analytical reports directly through our verified Certificate of Analysis database. For institution-wide procurement or bulk laboratory orders, institutional accounts are available via our bulk lab accounts portal.

Reconstitution Errors and Troubleshooting in Assays

In vitro data indicate that unexpected baseline variations in bioassays are frequently linked to reconstitution mistakes or vehicle incompatibility. Common procedural errors include using unpreserved sterile water for long-term multi-use stock solutions. Sterile water lacks antimicrobial agents (such as benzyl alcohol); once breached, unpreserved solutions must be used immediately or discarded to prevent bacterial contamination.

Another common technical issue is undissolved particulate matter resulting from incomplete hydration. If visual inspection reveals turbidity, cloudy suspensions, or undissolved micro-particles after gentle swirling, check the pH of the reconstituted medium or verify that the diluent volume was not under-calculated. Never use sonication bath methods for peptide dissolution, as local cavitation energy can degrade delicate amino acid chains. Always ensure complete solution clarity before introducing aliquots into quantitative assays.